Akkermansia muciniphila is a high-potency freeze-dried probiotic powder (400 billion AFU/g) for dietary supplement, sachet, drink powder and low-temperature functional-food applications.

For finished supplements, calculate the serving dose from the desired live-count target and include overage for expected stability loss during shelf life.

Mechanistic highlights

1. Microbiota modulation: Probiotic organisms can shift community composition and metabolite patterns depending on host baseline and finished serving design.
2. Barrier support: Gut-barrier effects are commonly linked with epithelial tight-junction signaling, mucus ecology and reduced inflammatory signaling in suitable models.
3. Process sensitivity: Viability is sensitive to heat, moisture, oxygen and compression stress, so cool processing and moisture-barrier packaging are important.

Safety & practical use

• Typical formulation range: Start from 50-100 mg/day for this high-potency material, then adjust by target CFU per serving and stability data.
• Processing: Add after heat treatment or into a cooled premix; avoid wet granulation and prolonged exposure above 40C.
• Storage: Keep frozen, sealed and dry; minimize repeated thawing and exposure to humid air.
• Allergen profile: No inherent milk, egg, fish, peanut, wheat, soy or gluten allergen is declared for the raw material; cross-contact depends on production control.
• Consumer caution: Immunocompromised consumers, infants, pregnant users or people with serious disease should use probiotic products under professional guidance.